Lee Junsung, Goh Unbyeol, Lee Hyoung-Jin, Kim Jiyoung, Jeong Moonkyoung, Park Ji-Ho
Bora Eye Hospital, Gwang-ju 61964, Republic of Korea.
Mol Pharm. 2017 Feb 6;14(2):423-430. doi: 10.1021/acs.molpharmaceut.6b00864. Epub 2016 Dec 27.
Efficient delivery of drugs to the retina is critical but difficult to achieve with current methods. There have been a number of attempts to use intravitreal injection of liposomes, artificial vesicles composed of a phospholipid bilayer, to overcome the limitations of conventional intravitreal injection (short retention time, toxicity, poor penetration, etc.). Here, we report an optimal liposomal formulation that can diffuse through the vitreous humor, deliver the incorporated agents to all retinal layers effectively, and maintain them for a relatively long time. We first delivered lipophilic compounds and phospholipid-conjugated hydrophilic agents to the inner limiting membrane using engineered liposomes. Subsequently, the agents penetrated the retina deeply, presumably via extracellular vesicles, nanoscale vesicles secreted from retinal-associated cells. These results suggest that this engineered liposomal formulation can leverage the biological transport system for effective retinal penetration of lipophilic and lipid-conjugated agents.
将药物有效递送至视网膜至关重要,但用目前的方法很难实现。人们已多次尝试通过玻璃体内注射脂质体(由磷脂双层构成的人工囊泡)来克服传统玻璃体内注射的局限性(如保留时间短、毒性、穿透性差等)。在此,我们报告一种优化的脂质体制剂,它能够扩散穿过玻璃体液,将所载药物有效递送至所有视网膜层,并能维持较长时间。我们首先使用工程化脂质体将亲脂性化合物和磷脂共轭亲水性药物递送至内界膜。随后,这些药物可能通过细胞外囊泡(视网膜相关细胞分泌的纳米级囊泡)深入穿透视网膜。这些结果表明,这种工程化脂质体制剂可利用生物转运系统,实现亲脂性和脂质共轭药物对视网膜的有效穿透。